Search Results - "Witthaut, Jörg"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Efficacy and Safety of Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: Short-Term Results From 2 Open-Label Studies by Witthaut, Jörg, MD, Jones, Graeme, MD, Skrepnik, Nebojsa, MD, PhD, Kushner, Harvey, PhD, Houston, Anthony, MD, Lindau, Tommy R., MD, PhD

    “…Purpose The JOINT I (United States) and JOINT II (Australia and Europe) studies evaluated the efficacy and safety of collagenase clostridium histolyticum (CCH)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Collagenase Clostridium histolyticum: emerging practice patterns and treatment advances by Warwick, David, Arandes-Renú, José M, Pajardi, Giorgio, Witthaut, Jörg, Hurst, Lawrence C

    “…This study aims to provide a comprehensive review of the role of Collagenase Clostridium histolyticum (CCH). This review is based on a literature review and…”
    Get more information
    Journal Article
  4. 4

    Treatment of Dupuytren’s contracture with collagenase clostridium histolyticum under clinical practice conditions: ReDUCTo study by Haerle, Max, Witthaut, Jörg, Giunta, Riccardo, Huscher, Dörte, Pieper, Lars, Kirch, Wilhelm, Pittrow, David

    “…Background: To date, real-life data on non-surgical correction of Dupuytren’s contracture with collagenase clostridium histolyticum injection (CCH, Xiapex) are…”
    Get full text
    Journal Article
  5. 5

    Determining Clinically Important Changes in Range of Motion in Patients with Dupuytren's Contracture by Witthaut, Jörg, Bushmakin, Andrew G, Gerber, Robert A, Cappelleri, Joseph C, Le Graverand-Gastineau, Marie-Pierre Hellio

    Published in Clinical drug investigation (01-11-2011)
    “…Background and Objective: Injectable collagenase Clostridium histolyticum is efficacious in correcting Dupuytren's contracture as assessed by changes in the…”
    Get full text
    Journal Article
  6. 6
  7. 7